T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Axalta
AXTA
$7.93B
| $616K | ﹤0.01% |
+24,300
| New | +$722K |
|
|
DMC
1852
Del Monte Corp
DMC
$1.44B
| $616K | ﹤0.01% |
15,600
| – | – |
|
1853
GATX Corp
GATX
$6.33B
| $616K | ﹤0.01% |
13,950
+2,500
| +22% | +$124K |
|
|
EVER
1854
DELISTED
Everbank Financial Corp
EVER
| $616K | ﹤0.01% |
31,900
+8,800
| +38% | +$175K |
|
|
CSGS
1855
DELISTED
CSG Systems International
CSGS
| $615K | ﹤0.01% |
19,980
+30
| +0.2% | +$929 |
|
|
NUVA
1856
DELISTED
NuVasive, Inc.
NUVA
| $612K | ﹤0.01% |
12,700
| – | – |
|
1857
Strategy Inc
MSTR
$38.2B
| $610K | ﹤0.01% |
31,060
+5,000
| +19% | +$99.1K |
|
|
TGI
1858
DELISTED
Triumph Group
TGI
| $610K | ﹤0.01% |
14,500
| – | – |
|
1859
Texas Roadhouse
TXRH
$13.6B
| $610K | ﹤0.01% |
16,400
+2,000
| +14% | +$75.6K |
|
|
OKSB
1860
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $607K | ﹤0.01% |
37,000
+3,000
| +9% | +$51.6K |
|
|
LTC
1861
LTC Properties
LTC
$2.1B
| $604K | ﹤0.01% |
14,150
+2,000
| +16% | +$84.8K |
|
|
SMLR
1862
DELISTED
Semler Scientific
SMLR
| $602K | ﹤0.01% |
215,777
-3,600
| -2% | -$11.1K |
|
1863
Stock Yards Bancorp
SYBT
$2.64B
| $601K | ﹤0.01% |
24,782
+900
| +4% | +$21.8K |
|
1864
Park National Corp
PRK
$3.76B
| $600K | ﹤0.01% |
6,655
| – | – |
|
1865
Primerica
PRI
$9.61B
| $599K | ﹤0.01% |
13,300
+3,682
| +38% | +$161K |
|
1866
Amkor Technology
AMKR
$14.3B
| $598K | ﹤0.01% |
133,153
-24,300
| -15% | -$120K |
|
1867
Chemours
CC
$2.3B
| $596K | ﹤0.01% |
+92,155
| New | +$965K |
|
1868
Rambus
RMBS
$10.8B
| $596K | ﹤0.01% |
50,500
| – | – |
|
1869
Scansource
SCSC
$1.06B
| $596K | ﹤0.01% |
16,800
| – | – |
|
1870
KB Home
KBH
$3.45B
| $595K | ﹤0.01% |
43,900
| – | – |
|
1871
Lithia Motors
LAD
$8.33B
| $595K | ﹤0.01% |
5,500
| – | – |
|
1872
First Financial Bancorp
FFBC
$3.6B
| $594K | ﹤0.01% |
31,142
| – | – |
|
|
BDN
1873
Brandywine Realty Trust
BDN
$542M
| $592K | ﹤0.01% |
48,043
| – | – |
|
1874
Neogen
NEOG
$2.59B
| $592K | ﹤0.01% |
35,067
+4,800
| +16% | +$94.5K |
|
1875
LiveRamp
RAMP
$2.31B
| $591K | ﹤0.01% |
29,900
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.